JP2025516703A5 - - Google Patents

Info

Publication number
JP2025516703A5
JP2025516703A5 JP2024567520A JP2024567520A JP2025516703A5 JP 2025516703 A5 JP2025516703 A5 JP 2025516703A5 JP 2024567520 A JP2024567520 A JP 2024567520A JP 2024567520 A JP2024567520 A JP 2024567520A JP 2025516703 A5 JP2025516703 A5 JP 2025516703A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
bispecific polypeptide
polypeptide according
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024567520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516703A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/067028 external-priority patent/WO2023220761A2/en
Publication of JP2025516703A publication Critical patent/JP2025516703A/ja
Publication of JP2025516703A5 publication Critical patent/JP2025516703A5/ja
Pending legal-status Critical Current

Links

JP2024567520A 2022-05-13 2023-05-15 ビオチン直交ストレプトアビジン系 Pending JP2025516703A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263342052P 2022-05-13 2022-05-13
US63/342,052 2022-05-13
PCT/US2023/067028 WO2023220761A2 (en) 2022-05-13 2023-05-15 Biotin orthogonal streptavidin system

Publications (2)

Publication Number Publication Date
JP2025516703A JP2025516703A (ja) 2025-05-30
JP2025516703A5 true JP2025516703A5 (cg-RX-API-DMAC7.html) 2026-05-20

Family

ID=88731171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024567520A Pending JP2025516703A (ja) 2022-05-13 2023-05-15 ビオチン直交ストレプトアビジン系

Country Status (4)

Country Link
US (1) US20250304705A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522281A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025516703A (cg-RX-API-DMAC7.html)
WO (1) WO2023220761A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4522281A2 (en) * 2022-05-13 2025-03-19 University of Utah Research Foundation Biotin orthogonal streptavidin system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451995B1 (en) * 1996-03-20 2002-09-17 Sloan-Kettering Institute For Cancer Research Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
EP2721072A4 (en) * 2011-06-20 2015-03-04 Akrivis Technologies Llc REAGENTS AND METHODS FOR BINDING TARGET MOLECULES BASED ON BISPECIFIC ANTIBODIES
WO2019190954A1 (en) * 2018-03-26 2019-10-03 Rootpath Genomics, Inc. Target binding moiety compositions and methods of use
US12643944B2 (en) * 2019-11-12 2026-06-02 Iprogen Biotech Inc. Antibody-payload conjugates with enhanced delivery domain and uses thereof
WO2021226290A1 (en) * 2020-05-05 2021-11-11 10X Genomics, Inc. Methods for identification of antigen-binding molecules
WO2022080486A1 (ja) * 2020-10-16 2022-04-21 シスメックス株式会社 ポリペプチド、多量体、固相、被検物質の測定方法および試薬キット
EP4522281A2 (en) * 2022-05-13 2025-03-19 University of Utah Research Foundation Biotin orthogonal streptavidin system

Similar Documents

Publication Publication Date Title
JP7685095B2 (ja) 多重特異性抗体とその作製及び使用方法
US11878058B2 (en) Antigen binding proteins that bind PD-L1
US11242391B2 (en) Antigen binding proteins that bind PD-1
CN107405397B (zh) 抗tim-3抗体
US11787863B2 (en) Multi-specific antibodies and methods of making and using thereof
JP7356970B2 (ja) 多重特異性抗体とその作製及び使用方法
JP6866294B2 (ja) 抗pd−l1抗体
CN107530420A (zh) 抗tim‑3抗体
CN107148281A (zh) 结合cxcr5的抗原结合蛋白
AU2020271467B2 (en) Antibodies against programmed death-ligand 1 and uses thereof
JPH0246297A (ja) モノクローナル抗体、抗体産生ハイブリドーマおよび抗体の製造法
US20240279333A1 (en) Multi-specific antibodies and methods of making and using thereof
CA3147887A1 (en) Composition and methods of targeting the pre-b cell receptor for the treatment of leukemias and lymphomas
HK40018991A (en) Multi-specific antibodies and methods of making and using thereof
HK40019010A (en) Multi-specific antibodies and methods of making and using thereof